{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:44:50Z","timestamp":1786373090250,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Kidney stones composed predominantly (50% or more) of calcium phosphate constitute up to 10% of all stones and 15%\u201320% of calcium stones, 80% of which are composed of calcium oxalate. Calcium phosphate is a minor component of up to 30% of calcium oxalate stones as well. The cause of calcium phosphate stones is often obscure but most often related to a high urine pH. Some patients with calcium phosphate stones may have incomplete renal tubular acidosis. Others have distal renal tubular acidosis characterized by hyperchloremic acidosis, hypocitraturia, and high urine pH. The use of carbonic anhydrase inhibitors such as acetazolamide, topiramate, and zonisamide leads to a similar picture. Treatment options to specifically prevent calcium phosphate stone recurrence have not been tested in clinical trials. Increases in urine volume and restriction of sodium intake to limit calcium excretion are important. Citrate supplementation is probably effective, although the concomitant increase in urine pH may increase calcium phosphate supersaturation and partially offset the inhibition of crystallization resulting from the increased urine citrate excretion and the alkali-associated reduction in urine calcium excretion. Thiazides lower urine calcium excretion and may help ensure the safety of citrate supplementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.00560112","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T00:40:05Z","timestamp":1337301605000},"page":"1172-1178","source":"Crossref","is-referenced-by-count":47,"title":["A Woman with Recurrent Calcium Phosphate Kidney Stones"],"prefix":"10.2215","volume":"7","author":[{"given":"David S.","family":"Goldfarb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20230811","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/S0022-5347(17)39145-0","article-title":"Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition.","volume":"142","author":"Mandel","year":"1989","journal-title":"J Urol"},{"key":"R2-17-20230811","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2215\/CJN.11321210","article-title":"Pathophysiology-based treatment of idiopathic calcium kidney stones.","volume":"6","author":"Coe","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-17-20230811","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1523-1755.2004.00803.x","article-title":"Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones.","volume":"66","author":"Parks","year":"2004","journal-title":"Kidney Int"},{"key":"R4-17-20230811","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1097\/01.ju.0000065592.55499.4e","article-title":"Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes.","volume":"169","author":"Mandel","year":"2003","journal-title":"J Urol"},{"key":"R5-17-20230811","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.urology.2008.12.049","article-title":"Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology.","volume":"73","author":"Carpentier","year":"2009","journal-title":"Urology"},{"key":"R6-17-20230811","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00240-010-0317-y","article-title":"Analysis of mixed stones is prone to error: A study with US laboratories using micro CT for verification of sample content.","volume":"38","author":"Krambeck","year":"2010","journal-title":"Urol Res"},{"key":"R7-17-20230811","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1053\/j.ajkd.2006.07.003","article-title":"Biochemical and stone-risk profiles with topiramate treatment.","volume":"48","author":"Welch","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"R8-17-20230811","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9343(03)00201-8","article-title":"Predictive value of kidney stone composition in the detection of metabolic abnormalities.","volume":"115","author":"Pak","year":"2003","journal-title":"Am J Med"},{"key":"R9-17-20230811","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/ki.1997.126","article-title":"Correspondence between stone composition and urine supersaturation in nephrolithiasis.","volume":"51","author":"Parks","year":"1997","journal-title":"Kidney Int"},{"key":"R10-17-20230811","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00240-011-0397-3","article-title":"Prevalence and densitometric characteristics of incomplete distal renal tubular acidosis in men with recurrent calcium nephrolithiasis.","volume":"40","author":"Arampatzis","year":"2012","journal-title":"Urol Res"},{"key":"R11-17-20230811","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-199111000-00001","article-title":"Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.","volume":"70","author":"Gault","year":"1991","journal-title":"Medicine (Baltimore"},{"key":"R12-17-20230811","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ng.404","article-title":"Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density.","volume":"41","author":"Thorleifsson","year":"2009","journal-title":"Nat Genet"},{"key":"R13-17-20230811","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1479-5876-9-201","article-title":"Calcium-sensing receptor and calcium kidney stones.","volume":"9","author":"Vezzoli","year":"2011","journal-title":"J Transl Med"},{"key":"R14-17-20230811","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0002-9343(80)90495-7","article-title":"Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.","volume":"69","author":"Pak","year":"1980","journal-title":"Am J Med"},{"key":"R15-17-20230811","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1523-1755.2003.00763.x","article-title":"Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis.","volume":"63","author":"Asplin","year":"2003","journal-title":"Kidney Int"},{"key":"R16-17-20230811","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.semnephrol.2008.01.005","article-title":"New insights into the pathogenesis of idiopathic hypercalciuria.","volume":"28","author":"Worcester","year":"2008","journal-title":"Semin Nephrol"},{"key":"R17-17-20230811","doi-asserted-by":"crossref","first-page":"F1017","DOI":"10.1152\/ajprenal.00223.2009","article-title":"A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers.","volume":"297","author":"Bergsland","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R18-17-20230811","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ackd.2008.10.010","article-title":"Prospects for dietary therapy of recurrent nephrolithiasis.","volume":"16","author":"Goldfarb","year":"2009","journal-title":"Adv Chronic Kidney Dis"},{"key":"R19-17-20230811","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1523-1755.2004.66029.x","article-title":"The effect of fruits and vegetables on urinary stone risk factors.","volume":"66","author":"Meschi","year":"2004","journal-title":"Kidney Int"},{"key":"R20-17-20230811","doi-asserted-by":"crossref","first-page":"c185","DOI":"10.1159\/000167271","article-title":"A randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis.","volume":"110","author":"Dussol","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"R21-17-20230811","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1681\/ASN.2009030276","article-title":"DASH-style diet associates with reduced risk for kidney stones.","volume":"20","author":"Taylor","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R22-17-20230811","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJMoa010369","article-title":"Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria.","volume":"346","author":"Borghi","year":"2002","journal-title":"N Engl J Med"},{"key":"R23-17-20230811","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0022-5347(17)35888-3","article-title":"Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.","volume":"150","author":"Barcelo","year":"1993","journal-title":"J Urol"},{"key":"R24-17-20230811","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0022-5347(17)46963-1","article-title":"Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.","volume":"134","author":"Preminger","year":"1985","journal-title":"J Urol"},{"key":"R25-17-20230811","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/0003-4819-130-8-199904200-00012","article-title":"Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide.","volume":"130","author":"Adams","year":"1999","journal-title":"Ann Intern Med"},{"key":"R26-17-20230811","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/end.1999.13.679","article-title":"Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis.","volume":"13","author":"Pearle","year":"1999","journal-title":"J Endourol"},{"key":"R27-17-20230811","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1681\/ASN.2004070543","article-title":"Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.","volume":"16","author":"Bushinsky","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R28-17-20230811","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.juro.2006.11.040","article-title":"Adverse metabolic side effects of thiazides: Implications for patients with calcium nephrolithiasis.","volume":"177","author":"Huen","year":"2007","journal-title":"J Urol"},{"key":"R29-17-20230811","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/00005344-199312050-00014","article-title":"Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.","volume":"22","author":"Borghi","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"R30-17-20230811","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1681\/ASN.2008070754","article-title":"Thiosulfate reduces calcium phosphate nephrolithiasis.","volume":"20","author":"Asplin","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R31-17-20230811","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1523-1755.2005.00599.x","article-title":"Direct and indirect costs of nephrolithiasis in an employed population: Opportunity for disease management?","volume":"68","author":"Saigal","year":"2005","journal-title":"Kidney Int"},{"key":"R32-17-20230811","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2215\/CJN.11331111","article-title":"Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers","volume":"7","author":"Leaf","year":"2012","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201207000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:42:10Z","timestamp":1786369330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201207000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.00560112","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}